Rite Aid Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Rite Aid stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAD, but not buy additional shares or sell existing shares.
View analyst ratings for Rite Aid or view top-rated stocks.

Wall Street analysts have given Rite Aid a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Rite Aid wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, June 24th 2021.
View our earnings forecast for Rite Aid.

Rite Aid Co. (NYSE:RAD) posted its earnings results on Wednesday, April, 14th. The company reported ($0.78) EPS for the quarter, beating analysts' consensus estimates of ($0.79) by $0.01. The business earned $5.92 billion during the quarter, compared to analyst estimates of $5.81 billion. Rite Aid had a negative net margin of 0.38% and a negative trailing twelve-month return on equity of 1.42%. Rite Aid's revenue was up 3.3% on a year-over-year basis. During the same period last year, the firm earned ($0.37) EPS.
View Rite Aid's earnings history.

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RAD stock has increased by 24.3% and is now trading at $17.56.
View which stocks have been most impacted by COVID-19.

Rite Aid shares reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

Rite Aid updated its FY 2022 earnings guidance on Thursday, June, 24th. The company provided earnings per share guidance of $-0.790--0.240 for the period, compared to the Thomson Reuters consensus estimate of $0.800. The company issued revenue guidance of $25.10 billion-25.50 billion, compared to the consensus revenue estimate of $24.66 billion.

3 analysts have issued twelve-month price targets for Rite Aid's shares. Their forecasts range from $6.00 to $18.00. On average, they anticipate Rite Aid's stock price to reach $13.67 in the next year. This suggests that the stock has a possible downside of 22.2%.
View analysts' price targets for Rite Aid or view top-rated stocks among Wall Street analysts.

169 employees have rated Rite Aid CEO Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among Rite Aid's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Rite Aid include Covetrus (CVET), 111 (YI), PetMed Express (PETS), China Jo-Jo Drugstores (CJJD), Progressive Care (RXMD), HealthWarehouse.com (HEWA), Dragon Jade International (DGJI), Dougherty's Pharmacy (MYDP), China Dasheng Biotechnology (CDBT) and Health Sciences Group (HESG).
View all of RAD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Rite Aid's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.08%), Renaissance Technologies LLC (3.08%), Great Lakes Advisors LLC (1.87%), Geode Capital Management LLC (1.69%), Dimensional Fund Advisors LP (1.64%) and Northern Trust Corp (1.38%).
View institutional ownership trends for Rite Aid.

RAD stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Alberta Investment Management Corp, Eversept Partners LP, Millennium Management LLC, Northern Trust Corp, Morgan Stanley, Cubist Systematic Strategies LLC, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Rite Aid or view top insider-selling stocks.

RAD stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Dimensional Fund Advisors LP, Point72 Asset Management L.P., Goldman Sachs Group Inc., Citigroup Inc., UBS Group AG, and JPMorgan Chase & Co..
View insider buying and selling activity for Rite Aid or or view top insider-buying stocks.

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RAD stock can currently be purchased for approximately $17.56.

Rite Aid has a market capitalization of $967.59 million and generates $24.04 billion in revenue each year. The company earns $-90,910,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis.

Rite Aid employs 50,000 workers across the globe.

The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Savings LLC, Envision Pharmaceutical, Envision Pharmaceutical Holdings LLC, EnvisionRx Puerto Rico Inc., First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG (PJC) USA LLC, JCG Holdings (USA) Inc., K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug Inc., Maxi Drug North Inc., Maxi Drug South L.P., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic LLC, RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group (PJC) USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, and Thrifty PayLess Inc..

Rite Aid was founded in 1968.

The official website for Rite Aid is www.riteaid.com.

Rite Aid is headquartered at 30 Hunter Lane, Camp Hill PA, 17105.

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]